Crataeva nurvala Buch.-Ham.
1. Taxonomic, Nomenclature & Therapeutic Summary Table
| Botanical Attribute | Pharmacognostic & Therapeutic Specification |
|---|---|
| Synonym | C. magna (Lour.) DC. |
| Family | Capparidaceae. |
| Habitat | Wild as well as cultivated in gardens all over India. |
| Ayurvedic | Varuna, Varana, Barnaa, Setu, Ashmarighna, Kumaarak, Tiktashaaka. |
| Unani | Baranaa. |
| Siddha / Tamil | Maavilingam. |
| Action | Bark—diuretic (finds application in urinary disorders, including urolithiasis, prostatic hypertrophy, neurogenic bladder and urinary infections; uterine and gastro-intestinal problems). Juice of the bark is given to women after childbirth. Extract of root bark, mixed with honey, is applied to scrofulous enlargements of glands. Whole plant powder—cholinergic in smooth muscles including urinary bladder. |
| Key Application | As antiurolithiatic. (Indian Herbal Pharmacopoeia.) |
| Dosage | Stem bark—20–30 g for decoction. (API Vol. I.) |
| Taxonomic Cohort | Genus Crataeva (1 documented species); Family Capparidaceae (9 documented species). |
2. Classical Nomenclature, Taxonomy & Biogeographical Context
Crataeva nurvala (taxonomically cited with authority Buch.-Ham.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Capparidaceae (primary family classification: Capparidaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. In classical and modern botanical literature, the species is cross-referenced under the botanical synonymy C. magna (Lour.) DC, which is synchronized to prevent taxonomic ambiguity across regional herbal formularies. Biogeographically, its documented habitat and ecological distribution span: Wild as well as cultivated in gardens all over India.
Across classical and vernacular Indian systems of medicine, Crataeva nurvala is recognized under distinct polyglot nomenclature: in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Varuna, Varana, Barnaa, Setu, Ashmarighna, Kumaarak, Tiktashaaka; in the Unani-Tibb materia medica (recorded in The National Formulary of Unani Medicine and CCRUM literature) as Baranaa; in the Siddha and Tamil medical tradition (compiled from the Formulary of Siddha Medicine and IMPCOPS Chennai) as Maavilingam. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.
3. Therapeutic Actions, Phytochemistry & Pharmacological Profile
In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Crataeva nurvala are: Bark—diuretic (finds application in urinary disorders, including urolithiasis, prostatic hypertrophy, neurogenic bladder and urinary infections; uterine and gastro-intestinal problems). Juice of the bark is given to women after childbirth. Extract of root bark, mixed with honey, is applied to scrofulous enlargements of glands. Whole plant powder—cholinergic in smooth muscles including urinary bladder. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias. Furthermore, international and national regulatory monographs highlight its validated key clinical application: As antiurolithiatic. (Indian Herbal Pharmacopoeia.).
Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Crataeva nurvala establish the following evidence base: The antiurolithic activity of the stem-bark is attributed to the presence of lupeol. Lupeol not only prevented the formation of vesical calculi, but also reduced the size of the preformed stones in the kidneys of calculogenic rats. It also reversed the biochemical parameters in urine, blood and serum towards normal. The stem bark also exhibit antiinflammatory activity, and is reported to stimulate bile secretion, appetite and bowel movement.
In specialized pharmacognostic classifications, Crataeva nurvala is also listed among standardized commercial herbal extracts used in India with defined quantitative phytochemical markers; and represented by authenticated macro-photographic crude drug specimens in institutional pharmacognostic collections.

Figure 1: Authenticated crude herb specimen — Crataeva nurvala bark.

Botanical Reference 1: Crataeva nurvala — Wikimedia Commons

Botanical Reference 2: Crataeva nurvala — Wikimedia Commons

Botanical Reference 3: Crataeva nurvala — Wikimedia Commons
4. Comparative Genus & Family Pharmacognosy
Within Indian medicinal flora, Crataeva nurvala stands as a distinct representative of the genus Crataeva. Its therapeutic profile underscores the role of selectively utilized medicinal genera alongside larger polytypic genera.
At the family level, Capparidaceae encompasses 9 documented medicinal species (0.50% of the 1,814-species flora). Other representative medicinal members of Capparidaceae include: Cadaba fruticosa (Kodhab), Capparis aphylla (Karira), Capparis moonii (Rudanti), Capparis sepiaria (Himsraa), Cleome brachycarpa (Madhio). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

Figure 2: Quantitative documentation profile across all 9 medicinal species of family Capparidaceae.
5. Pharmacopoeial Standards, Posology & Reference Framework
For clinical and traditional dispensing, the standardized posology and crude herb dosage for Crataeva nurvala are prescribed as follows: Stem bark—20–30 g for decoction. (API Vol. I.). Crude drug dosages are calibrated against The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and the Standard Nomenclature of Ayurvedic Medicinal Plants published by the Central Council for Research in Ayurveda and Siddha (CCRAS). Classical and modern pharmacognostic synchronization for Crataeva nurvala integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.